From a genetic standpoint, EMC is typified by a reciprocal chromosome translocation involving the Nuclear Receptor Subfamily 4 Group A (NR4A3) gene on chromosome 9q31.1 (previously mapped to 9q22), in a near-diploid karyotype. The gene discussed is NR4A3; the disease is extraskeletal myxoid chondrosarcoma.